Ovid Therapeutics (NASDAQ:OVID) Stock, Quote.Headers.trade-ideas

Ovid Therapeutics

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Wall Street bull

Earnings

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ALLG

AVTE

MBIO

OVID

WKHS

Nasdaq Surges Over 200 Points; Aaron&#39;s Shares Jump

movers

Movers

AGRI

AMCX

ATRA

BIMI

BJDX

BMEA

BTDR

CETX

CNSP

EVTV

FCEL

FLFV

KAVL

LRHC

LXRX

MEDS

MIRM

MYTE

NDRA

OUST

PRMW

SCNI

SCPX

SPCE

SYNX

TRNR

VERO

XPOF

XTLB

XXII

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Crude-oil-4-logo

Crude Oil Rises 1%; Mustang Bio Shares Spike Higher

Ovid Therapeutics Inc

<a target="_blank" href="https://www.benzinga.com/topic/big-banks?page=5" rel="noreferrer noopener">Major U.S. banks</a>, including JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), and Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), filed a lawsuit against the Federal Reserve on Tuesday, challenging the transparency of its annual stress test procedures.
Leading banking and business organizations, including the Bank Policy Institute (BPI), American Bankers Association (ABA), U.S. Chamber of Commerce, Ohio Bankers League, and Ohio Chamber of Commerce, joined the <a target="_blank" href="https://bpi.com/banks-and-business-groups-file-legal-challenge-against-federal-reserve-over-flawed-stress-testing-framework/" rel="noreferrer noopener">lawsuit </a>against the Federal Reserve. These tests, which assess banks&#8217; resilience during economic crises, are a cornerstone of financial risk management. However, the plaintiffs argue that the current system violates federal law by excluding required public input.
The litigation addresses long-standing concerns about the opacity of the Federal Reserve&#8217;s stress testing procedures, which the plaintiffs claim lead to excessive and volatile capital requirements. These charges, they say, hinder banks&#8217; ability to lend, support households and businesses, and contribute to economic growth. While acknowledging the importance of stress testing, the groups emphasize the need for reforms to create a fairer and more predictable regulatory environment.
Greg Baer, CEO of the BPI, stated that the current regime results in inaccurate and excessive capital charges, which reduce lending and stifle economic growth.
Rob Nichols, CEO of the ABA, criticized the stress tests for shielding critical supervisory models from public scrutiny.
Michael Adelman, CEO of the Ohio Bankers League, stressed that the lawsuit is about enforcing compliance with federal laws.
Tom Quaadman of the U.S. Chamber of Commerce highlighted the detrimental effects of the current system on small businesses, which rely on bank lending for growth.
The lawsuit follows the Fed&#8217;s <a href="https://www.federalreserve.gov/newsevents/pressreleases/bcreg20241223a.htm">recent </a>announcement to overhaul its stress test regime and seek public input on proposed changes in early 2025, the Wall Street Journal <a href="https://www.wsj.com/finance/regulation/banks-sue-federal-reserve-over-lack-of-transparency-in-stress-testing-0db6a002" target="_blank" rel="noreferrer noopener">reports</a>.
The lawsuit highlights the economic implications of unexpected capital burdens, stating they could impose &#8220;billions of dollars&#8221; in costs and negatively impact the broader economy.
The banks also noted that a statute of limitations on stress-test rule changes will expire in February, prompting their decision to file the suit now.
The latest test assessed how banks would manage a 40% decline in commercial real estate prices and a 36% drop in house prices.
The Federal Reserve evaluates these results to determine the total capital banks need to absorb potential losses, the Financial Times <a target="_blank" href="https://www.ft.com/content/56def327-dbf7-42f1-8aba-218259ebd4a1" rel="noreferrer noopener">reports</a>.
Since the 2008 financial crisis, banks have faced increased regulatory scrutiny, including stringent capital requirements.
Executives like Jamie Dimon of JPMorgan Chase and Brian Moynihan of Bank of America have criticized these rules for driving financial activities into less transparent markets.
The Federal Reserve&#8217;s Vice Chair for Supervision, Michael Barr, had proposed raising capital requirements for large banks but delayed those plans following industry opposition.
Six leading <a target="_blank" href="https://www.benzinga.com/government/24/06/39506407/6-biggest-us-banks-ramp-up-buybacks-undeterred-by-stress-tests" rel="noreferrer noopener">U.S. banks, including</a> JPMorgan Chase, Bank of America, Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), and Citigroup repurchased over $14 billion in shares in the first quarter.
In June, Bank of America analyst Ebrahim H. Poonawala criticized the Federal Reserve&#8217;s <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39531404/bank-of-america-analyst-highlights-fed-stress-test-opacity-varying-bank-impacts-gol" rel="noreferrer noopener">stress test process</a>, highlighting its &#8220;inherent opacity.&#8221; These evaluations, which assess banks&#8217; resilience under severe economic scenarios, revealed varying impacts on capital requirements. Poonawala noted that while banks demonstrated adequate buffers, the tests showed higher-than-expected losses.
In June, JPMorgan analyst Vivek Juneja analyzed the Federal Reserve&#8217;s <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39536951/bank-stress-tests-much-bigger-surprise-than-expected-will-delay-future-investment-p" target="_blank" rel="noreferrer noopener">annual stress test results</a>, highlighting larger-than-expected increases in stress capital buffers for major banks. He noted that the elevated capital requirements could delay or reduce long-term capital return strategies for these institutions.
Image via Shutterstock.

Legal

Media

Banks And Business Groups Challenge Fed's Stress Test Rules

As of Dec. 26, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">CorVel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVL#NASDAQ">CRVL</a>)</h3>
<ul>
<li>On Dec. 24, CorVel announced the effectiveness of three-for-one forward stock split. The company's stock surged around 38% over the past six months and has a <a href="https://www.benzinga.com/quote/CRVL">52-week high of $125.52</a>.</li>
<li>RSI Value: 84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CRVL Price Action: Shares of CorVel closed at $115.82 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">SES AI Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>)</h3>
<ul>
<li>On Oct. 31, SES AI posted third-quarter GAAP loss of 9 cents per share. &#8220;SES AI achieved several milestones in the third quarter, including building revenue pipeline from UAM and drones including with one of the world&#8217;s largest wireless communication providers, SoftBank. We also passed the GB38031-2020 global EV industry safety tests for its 100Ah Li-Metal cells, a major step towards C-samples and start-of-production for EV,&#8221; stated Dr. Qichao Hu, Founder and CEO. &#8220;Our ‘All-in on AI strategy&#8217; continues to power our success with our first revenue using our AI-accelerated battery material discovery expected in the fourth quarter of 2024 this year.&#8221; The company's stock gained around 82% over the past five days and <a href="https://www.benzinga.com/quote/SES">has a 52-week high</a> of $1.92.</li>
<li>RSI Value: 79</li>
<li>SES Price Action: Shares of SES closed at $0.71 on Tuesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42669200/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks With Over 4% Dividend Yields</a></li>
</ul>

Short Ideas

Pre-Market Outlook

CRVL

Top 2 Health Care Stocks You May Want To Dump This Quarter

HGTV home renovation stars Jonathan and Drew Scott – best known as <a href="https://www.benzinga.com/real-estate/24/10/41601236/property-brothers-say-in-20-years-no-young-person-will-be-able-to-afford-a-home">the Property Brothers –</a> are fearful that Trump&#8217;s proposed tariffs could send construction costs soaring.
The brothers' native Canada, along with Mexico, has been in the President-elect&#8217;s tariff crosshairs, threatening that if both countries don&#8217;t stop the flow of migrants and drugs into the U.S., they will be hit economically through trade tariffs.
&#8220;Jonathan and I love the idea of domestic-made products,&#8221; real estate agent Drew Scott, one-half of the 6ft 5&#8243; identical twins, told<a href="https://www.bloomberg.com/news/features/2024-12-17/property-brothers-turned-reality-tv-home-renovation-craze-into-a-business-empire"> </a>Bloomberg. &#8220;There is a balance we need to strike,&#8221; Jonathan, the contractor of the two, added. &#8220;Blanket tariffs are not good for any economy,&#8221; he said. If those tariffs include essential building products such as steel and lumber, the results could be devastating for homeowners looking to renovate and the construction industry, causing newly built homes to increase prices sharply.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>
<h2 class="wp-block-heading">A $2.8 Billion Home Goods Empire and $200 Million Net Worth</h2>
The Scott Brothers have a lot at stake. They have a $2.8 billion home goods brand empire but, as TV hosts, they also have the added benefit of not simply relying on selling products to pay the bills. &#8220;We&#8217;ve made money in every kind of market possible,&#8221; Drew said. &#8220;Upmarket, down markets, buyer&#8217;s seller&#8217;s markets, it doesn&#8217;t matter.&#8221;
The brothers feel that extensive renovation projects and house flips will likely take a back seat in 2025 if interest rates do not come down. A trade war will only exacerbate things. The Scotts have plenty of outlets to invest their $200 million (according to Celebrity Net Worth) net worth if house flips falter.
See Also: This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a>
<h2 class="wp-block-heading">Endorsement Magnets And Multiple Real Estate Reality TV Shows</h2>
They have created a fixer-upper reality TV empire, with dozens of HGTV shows, books and even a cruise under their umbrella. In addition, the Scotts have, according to Variety,<a href="https://variety.com/2022/tv/news/property-brothers-interview-billion-dollar-lifestyle-empire-1235439674/"> </a>multiple endorsements, appearing in ads for <a href="https://www.benzinga.com/news/24/12/42489378/whats-going-on-with-jpmorgan-chase-shares">Chase Bank</a>, LendingTree, ADT security, Dish Network and American Family Insurance, to name a few. The LA-based production company, Scott Brothers Entertainment, is home to their many TV shows. At the same time, their retail and e-commerce home-furnishing product lines are ubiquitous in multiple retail outlets such as Living Spaces, Macy's, <a href="https://www.benzinga.com/insights/options/24/12/42619016/home-depots-options-frenzy-what-you-need-to-know">Home Depot</a>, Lowe&#8217;s, Wayfair and Amazon. They also have a &#8220;Property Brothers Home Design&#8221; mobile app that debuted in 2019 with publisher Storm8. Everything is housed under their multibillion-dollar business, Scott Brothers Global.
<h2 class="wp-block-heading">A Venture Capital Fund</h2>
In addition, the brothers have created The Healthy Home Innovation Fund, a VC fund for home-related businesses and innovations.
&#8220;We said, &#8216;Well, why don&#8217;t we create a fund where we&#8217;re actually putting our money where our mouth is, find these young talents, get their ideas through our machine and to the next level?'&#8221; Jonathan told<a href="https://www.inc.com/chloe-aiello/the-property-brothers-built-a-multibillion-dollar-empire-now-theyre-helping-other-entrepreneurs.html"> I</a>nc.com. &#8220;And that&#8217;s the goal.&#8221;
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
The brothers founded the Healthy Home Innovation Fund with GroundBreak Ventures and partner Sanders Lee in 2024. It is raising $50 million to $80 million to deploy to startups developing the latest technology for sustainable home improvement.
&#8220;Whether it&#8217;s decarbonizing your house, heat pumps, air quality in your home, how you transact, buy, sell, renovate or design – anything that touches home fits our pillars,&#8221; Drew added, explaining that he and Jonathan are &#8220;leveraging our brand and our facial awareness to help scale up some of these startups to really make them known, so we can bring the price points down to make it feasible for families.&#8221;
Tariffs or not, the Property Brothers' home renovation empire seems unlikely to crumble anytime soon.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Real Estate

The Property Brothers Fear Trump's Tariffs Could Send Construction Costs Soaring

WIIM

Meiwu Technology shares are trading lower. The company regained Nasdaq compliance.

NNDM

Nano Dimension shares are trading higher after the company announced a CEO transition.

SNAL

Snail shares are trading higher after Snail Games USA announced the launch of 'ARK: Ultimate Mobile Edition worldwide' on App Store and Google Play Store.

Snail Games Expands ARK Franchise With Launch Of ARK: Ultimate Mobile Edition And Updates To ARK: Extinction Ascended And Bob's Tall Tales: Wasteland War; Hits 1M Mobile Downloads In 24 Hours And 62% DAU Surge On Steam During Launch Weekend

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.
Shares of MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) fell sharply in today's pre-market trading following the company's announcement to issue more shares to finance additional Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) acquisitions. This move aligns with MicroStrategy's ongoing strategy to <a href="https://www.benzinga.com/quote/MSTR">bolster its Bitcoin reserves</a>.
MicroStrategy shares fell 3.5% to $345.65 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>NeuroPace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) shares dipped 10.1% to $10.01 in pre-market trading.</li>
<li>Delcath Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) declined 10% to $10.21 in pre-market trading.</li>
<li>Design Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGN#NASDAQ">DSGN</a>) fell 8.6% to $5.80 in pre-market trading.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) fell 8.6% to $11.21 in pre-market trading.</li>
<li>SunCoke Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXC#NYSE">SXC</a>) dipped 8.2% to $9.90 in pre-market trading.</li>
<li>Gray Television, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTN#NYSE">GTN</a>) fell 5.9% to $2.8505 in pre-market trading.</li>
<li>Portland General Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) slipped 2.5% to $42.69 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42669200/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks With Over 4% Dividend Yields</a></li>
</ul>

$BTC

CGEM

DCTH

DSGN

MSTR

NPCE

MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

The most oversold stocks in the utilities sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">National Grid plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGG#NYSE">NGG</a>)</h3>
<ul>
<li>On Nov. 20, National Grid named Steve Smith as Chief Strategy and Regulation Officer. &#8220;It&#8217;s a privilege to be appointed to this role at the most exciting time for the energy sector in decades,&#8221; said Steve Smith &#8220;The strategy and regulation teams already deliver outstanding work to ensure National Grid is set up for success and that we continue to put our customers first. I am very much looking forward to continuing to build on this, as I take up the role on a permanent basis.&#8221; The company's stock fell around 6% over the past month and has a <a href="https://www.benzinga.com/quote/NGG">52-week low of $55.13</a>.</li>
<li>RSI Value: 24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>NGG Price Action: Shares of National Grid fell 0.3% to close at $58.86 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1">latest NGG news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="913" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084059/image-204.png" alt="" class="wp-image-707637" style="width:520px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084059/image-204.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084059/image-204-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084059/image-204-768x708.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure>
<h3 class="wp-block-heading">American Electric Power Company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Dec. 12, JP Morgan analyst Jeremy Tonet downgraded American Electric Power from Overweight to Neutral and lowered the price target from $109 to $102. The company's stock fell around 7% over the past month and <a href="https://www.benzinga.com/quote/AEP">has a 52-week low</a> of $75.22.</li>
<li>RSI Value: 29</li>
<li>AEP Price Action: Shares of American Electric Power fell 0.5% to close at $92.37 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1">AEP stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="921" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084230/image-205.png" alt="" class="wp-image-707638" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084230/image-205.png 921w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084230/image-205-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084230/image-205-768x706.png 768w" sizes="(max-width: 921px) 100vw, 921px" /></a></figure>
NextEra Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>)
<ul>
<li>On Dec. 12, Scotiabank analyst Andrew Weisel maintained NextEra Energy with a Sector Outperform and raised the price target from $92 to $96. The company's stock fell around 6% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/NEE">low of $53.95</a>.</li>
<li>RSI Value: 27</li>
<li>NEE Price Action: Shares of NextEra Energy gained 0.6% to close at $72.91 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1">breakout in NEE shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="872" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084658/image-206.png" alt="" class="wp-image-707645" style="width:674px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084658/image-206.png 872w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084658/image-206-300x288.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26084658/image-206-768x737.png 768w" sizes="(max-width: 872px) 100vw, 872px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42669200/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks With Over 4% Dividend Yields</a></li>
</ul>

Long Ideas

Top 3 Utilities Stocks You'll Regret Missing In December

LAES

SEALSQ Launches SEALQUANTUM.com Lab To Advance Quantum-Safe Encryption And Post-Quantum Research, Strengthening Cybersecurity Solutions Against Emerging Quantum Threats

Management

Nano Dimension Appoints Julien Lederman As Interim CEO Following Termination Of Yoav Stern; Board Initiates Search For Permanent CEO

COEP

Coeptis Therapeutics Holdings shares are trading higher after the company announced it acquired NexGenAI Affiliated Network platform and the official launch of Coeptis Technologies.

SPRC

SciSparc shares are trading higher after the company announced it received its first shipment of vehicles manufactured by Anhui Jianghuai Automobile Group.

Biotech

General

CASI

CASI Pharmaceuticals Announces FDA Clinical Hold On CID-103 For Kidney Transplant AMR; IND Application For Phase 1-2 Study In Chronic Immune Thrombocytopenia Remains Open With Accrual Expected To Begin Q1 2025; FDA To Provide Written Response Before Deadline

EVER

EverQuote shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy.

NTIP

Network-1 Initiates Patent Litigation Against Citadel Securities And Jump Trading For Patents-in-Suit, Which Are Part Of The HFT Patent Portfolio Acquire By HFT Solutions In 2022

Macro Economic Events

Econ #s

Economics

USA Jobless Claims 4-Week Avg. 226.50K; 225.50K Prior

USA Continuing Jobless Claims 1,910K Vs 1,880K Est.; 1,864K Prior

USA Initial Jobless Claims 219K Vs 223K Est.; 220K Prior

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

COIN

KULR

KULR Technology Launches Bitcoin Treasury With $21M Purchase Of 217.18 BTC At An Average Price Of $96,556.53, Allocating Up To 90% Of Surplus Cash To Bitcoin Investments; Selects Coinbase Prime For Custody, USDC, And Self-Custodial Wallet Services To Support Its Bitcoin Treasury Strategy

Oppenheimer analyst Francois Brisebois maintained a Hold rating on Ovid Therapeutics (OVID – Research Report) today. The company's shares closed ye...

Oppenheimer Sticks to Their Hold Rating for Ovid Therapeutics (OVID)

H.C. Wainwright analyst Ram Selvaraju has reiterated their bullish stance on OVID stock, giving a Buy rating on September 27. Ram Selvaraju has giv...

Buy Rating Affirmed for Ovid Therapeutics on Promising Safety Profile and Robust Pipeline Progress

Thomas Shrader, an analyst from BTIG, maintained the Buy rating on Ovid Therapeutics (OVID – Research Report). The associated price target remains ...

Ovid Therapeutics: Promising Safety Profile and Growth Potential Underpin Buy Rating

Reports Q3 revenue $173,000, consensus $90k. "The biopharmaceutical industry is entering an exciting new era of neurotherapeutics, and we are poise...

Ovid Therapeutics reports Q3 EPS (20c), consensus (20c)

Ovid Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $0.17M beats by $0.1M

Ritu Baral, an analyst from TD Cowen, has initiated a new Buy rating on Ovid Therapeutics (OVID). Ritu Baral has given his Buy rating due to a comb...

Ovid Therapeutics: Strategic Developments and Financial Stability Lead to Buy Rating

Wedbush analyst Laura Chico maintained a Buy rating on Ovid Therapeutics (OVID – Research Report) today and set a price target of $4.00. The compan...

Ovid Therapeutics (OVID) Gets a Buy from Wedbush

Ovid Therapeutics (OVID) will present four posters that support the Company's OV329 and OV350 pipeline programs for the treatment of conditions cau...

Ovid to present posters on pipeline program for neuronal hyperexcitability

In a report released yesterday, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Ovid Therapeutics (OVID – Research Report), with a pr...

Ovid Therapeutics' KCC2 Activators Show Promise for Excitability Disorders: Analyst Recommends Buy with $3 Price Target

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Beam Therapeutics (BEAM – Research Report) and Ovid ...

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM) and Ovid Therapeutics (OVID)

BEAM

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID

Ligand Reports Second Quarter 2024 Financial Results

Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Ovid Therapeutics to Present at Upcoming September Investor Conferences

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Health Care

Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin

Ovid Therapeutics to Host Investor Event

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting

Comments

Ovid Therapeutics

Ovid Therapeutics (OVID) Forecast

Ovid Therapeutics (NASDAQ:OVID) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga